Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Advances of Tubulin Inhibitors Targeting the Colchicine Binding Site for Cancer Therapy
Mohammed Hawash
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1843-1843
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Novel tetrahydroisoquinolines as DHFR and CDK2 inhibitors: synthesis, characterization, anticancer activity and antioxidant properties
Eman M. Sayed, Etify A. Bakhite, Reda Hassanien, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 9
Design, synthesis and biological evaluation of 1,2,3-triazole benzothiazole derivatives as tubulin polymerization inhibitors with potent anti-esophageal cancer activities
Bowen Wu, Wenjing Huang, Yunhe Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116118-116118
Closed Access | Times Cited: 7
Exploration of isoxazole analogs: Synthesis, COX inhibition, anticancer screening, 3D multicellular tumor spheroids, and molecular modeling
Mohammed Hawash, Samer Abdallah, Mahmoud Abudayyak, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116397-116397
Closed Access | Times Cited: 6
Impact of trifluoromethyl and sulfonyl groups on the biological activity of novel aryl-urea derivatives: synthesis, in-vitro, in-silico and SAR studies
Farid M. Sroor, Karima F. Mahrous, Heba A.M. Abd El‐Kader, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Advances in dual-targeting inhibitors of HDAC6 for cancer treatment
Zhicheng Gu, Shuxian Lin, Junhui Yu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116571-116571
Closed Access | Times Cited: 5
New Thiazole Carboxamide Derivatives as COX Inhibitors: Design, Synthesis, Anticancer Screening, In Silico Molecular Docking, and ADME Profile Studies
Mohammed Hawash, Nidal Jaradat, Rozan Sabobeh, et al.
ACS Omega (2023) Vol. 8, Iss. 32, pp. 29512-29526
Open Access | Times Cited: 13
An Update on the Recent Advances and Discovery of Novel Tubulin Colchicine Binding Inhibitors
Haoxiang Weng, Jinlong Li, Huajian Zhu, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 73-95
Open Access | Times Cited: 12
Triphenyltin(IV) Carboxylates with Exceptionally High Cytotoxicity against Different Breast Cancer Cell Lines
Ivana Predarska, Mohamad Saoud, Ibrahim Morgan, et al.
Biomolecules (2023) Vol. 13, Iss. 4, pp. 595-595
Open Access | Times Cited: 12
An update on the development on tubulin inhibitors for the treatment of solid tumors
Prasanna Anjaneyulu Yakkala, Shaik O. Rahaman, P.S. Lakshmi Soukya, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 3, pp. 193-220
Closed Access | Times Cited: 3
6-Bromo quinazoline derivatives as cytotoxic agents: design, synthesis, molecular docking and MD simulation
Leila Emami, Maryam Hassani, Pegah Mardaneh, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Anticancer Activity of Thiophene Carboxamide Derivatives as CA-4 Biomimetics: Synthesis, Biological Potency, 3D Spheroid Model, and Molecular Dynamics Simulation
Mohammed Hawash, Mohammed T. Qaoud, Nidal Jaradat, et al.
Biomimetics (2022) Vol. 7, Iss. 4, pp. 247-247
Open Access | Times Cited: 20
Synthesis, in silico modelling, and in vitro biological evaluation of substituted pyrazole derivatives as potential anti-skin cancer, anti-tyrosinase, and antioxidant agents
Samuel Boateng, Tithi Roy, Kara Torrey, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 9
In Vitro and In Silico Evaluation of Antiproliferative Activity of New Isoxazolidine Derivatives Targeting EGFR: Design, Synthesis, Cell Cycle Analysis, and Apoptotic Inducers
Fahad M. Alminderej, Siwar Ghannay, Mohamed O. Elsamani, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1025-1025
Open Access | Times Cited: 9
Tubulin inhibitors. Selected scaffolds and main trends in the design of novel anticancer and antiparasitic agents
M Podolak, Serhii Holota, Yaroslava Deyak, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107076-107076
Open Access | Times Cited: 9
Discovery of a novel Coumarin-Dihydroquinoxalone derivative MY-673 as a tubulin polymerization inhibitor capable of inhibiting the ERK pathway with potent anti-gastric cancer activities
Jian Song, Shuyu Wang, Xiao Wang, et al.
Bioorganic Chemistry (2023) Vol. 137, pp. 106580-106580
Closed Access | Times Cited: 8
Synthesis and characterization of bis-amide SSE1917 as a microtubule-stabilizing anticancer agent
Sana Iqbal, Farhat Firdous, Muhammad Furqan, et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107094-107094
Closed Access | Times Cited: 2
Trends in Anti-Tumor Effects of Pseudomonas aeruginosa Mannose-Sensitive-Hemagglutinin (PA-MSHA): An Overview of Positive and Negative Effects
Dragica Božić, Jovana Živanović, Katarina Živančević, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 524-524
Open Access | Times Cited: 2
PM534, an Optimized Target-Protein Interaction Strategy through the Colchicine Site of Tubulin
Daniel Lucena‐Agell, María José Guillén, Ruth Matesanz, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 2619-2630
Open Access | Times Cited: 2
Research progress of LSD1-based dual-target agents for cancer therapy
Xiaojuan Yang
Bioorganic & Medicinal Chemistry (2024) Vol. 101, pp. 117651-117651
Closed Access | Times Cited: 2
N-Benzyl arylamide derivatives as novel and potent tubulin polymerization inhibitors against gastric cancers: Design, structure–activity relationships and biological evaluations
Jian Song, Shenghui Wang, Qiu-Ge Liu, et al.
Chinese Chemical Letters (2024) Vol. 36, Iss. 2, pp. 109678-109678
Closed Access | Times Cited: 2
In Vitro Antitumor and Antioxidant Capacity as well as Ameliorative Effects of Fermented Kefir on Cyclophosphamide-Induced Toxicity on Cardiac and Hepatic Tissues in Rats
Songül Çetik Yıldız, Cemil Demir, Mustafa Cengiz, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1199-1199
Open Access | Times Cited: 2
Targeting hematological malignancies with isoxazole derivatives
Monika Majirská, Martina Bago Pilátová, Z Kudlicková, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104059-104059
Open Access | Times Cited: 2
The cytotoxic natural compound erianin binds to colchicine site of β-tubulin and overcomes taxane resistance
Wei Yan, Yongzhao Zhou, Xue Yuan, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107569-107569
Closed Access | Times Cited: 2
A Novel Pyrazole Exhibits Potent Anticancer Cytotoxicity via Apoptosis, Cell Cycle Arrest, and the Inhibition of Tubulin Polymerization in Triple-Negative Breast Cancer Cells
Edgar A. Borrego, Cristina D. Guerena, Austre Y. Schiaffino Bustamante, et al.
Cells (2024) Vol. 13, Iss. 14, pp. 1225-1225
Open Access | Times Cited: 2
Unveiling the potential: 1,3-benzodioxole-based ionic liquids as dynamic players against cancer
Sangeeta Yadav, Anjana Sarkar, Ravi Tomar
Journal of Molecular Liquids (2024), pp. 126002-126002
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top